Skip to content

Author

M. Juruena

We have 2 of 34 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

716. A randomised-controlled feasibility study of ketamine for the treatment of depression with anorexia nervosa

Abstract Background Approximately a third of people with anorexia nervosa (AN) develop a severe and enduring form of the illness, which is often accompanied by depression. This can be a key barrier to recovery. Anti-depressant medications are less effective in treating depression in patients with acute AN, thus new pha...

J. Keeler, H. Himmerich, J. Treasure et al. · 0 citations
Review Open access Jul 2026

Individualized pharmacogenomics for depressive episodes: A narrative review.

This narrative review aims to summarize key pharmacogenes and genetic variants implicated in the pharmacological treatment of MDD and differentiate genes with established clinical actionability from those requiring further evidence, and evaluate their current and future roles in precision psychiatry.

Michel Haddad, L. Dieckmann, Giovana Regina Weber Hoss et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.